COMMUNIQUÉS West-GlobeNewswire

Relievant Announces Publication of Level I INTRACEPT Study
25/06/2019
Intracept® Procedure Demonstrates Highly Significant Treatment Effect vs. Standard Care MINNEAPOLIS, June 25, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company focused on [...]
Comfort Keepers® declares June 26 National Day of Joy, releases State of Joy survey results
25/06/2019
Survey finds seniors are the nation’s most joyful demographic IRVINE, California, June 25, 2019 (GLOBE NEWSWIRE) -- To raise awareness about the need for more joy in the world, and to encourage people to spread joy to [...]
AXIM® Biotechnologies Signs Supply Agreement to Register Cannabinoid Oral Care Products in Clinical Trials for Gingivitis and Gum Disease
25/06/2019
Leading Cannabinoid Biotech Company Announces Use of Oral Care Product Line in Registration for Clinical Trials in Australia and New Zealand NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (OTC [...]
Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients
25/06/2019
Expands Options for Patients with Potential for Reduced Reconstitution Time and Infusion Volume SEATTLE, June 25, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on [...]
Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company
25/06/2019
MIRAMAR, Fla., June 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (“Generex”) ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that Generex has signed a [...]
XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa
25/06/2019
AUSTIN, Texas, June 25, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announces that Alice Gottlieb M.D., Ph.D., will Chair the Company’s upcoming Phase II study in Hidradenitis Suppurativa (HS). Dr. Gottlieb is [...]
Teladoc Health Names Mala Murthy as Chief Financial Officer
25/06/2019
PURCHASE, NY, June 25, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced that it has named seasoned financial leader Mala Murthy as chief financial officer. Joining most [...]
Marrone Bio Innovations allowed key claims by U.S. Patent and Trademark Office for Grandevo® WDG
25/06/2019
Company Further Strengthens Intellectual Property Portfolio With Notice of Allowance for Claims Covering Composition And Method of Manufacturing DAVIS, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations [...]
Driven Deliveries Inc. Completes Acquisition of Ganjarunner, Inc. First-Year Revenue Expected to Exceed $4 Million
25/06/2019
The transaction significantly bolsters Driven’s Brand-to-Consumer delivery and will expand the Ganjarunner brand throughout California SAN DIEGO, June 25, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the [...]
Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO™ (celiprolol) in vEDS Patients
25/06/2019
NEWTON, Mass., June 25, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Hemostemix Announces Resignation of CFO
25/06/2019
CALGARY, Alberta, June 25, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and commercializing innovative [...]
REPEAT - AgraFlora Organics Provides Guidance and Facility Expansion Updates at Toronto, ON Brewhouse; Increases Production Capacities by 30%
25/06/2019
VANCOUVER, British Columbia, June 25, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Data Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting Highlights Potential of Progenics’ PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer
25/06/2019
NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer
25/06/2019
EAST RUTHERFORD, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors
25/06/2019
MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American commercial [...]
HealthLynked Streamlines Patient Check-in with the Release of its New Application for Healthcare Practices
25/06/2019
NAPLES, Fla., June 25, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp (OTCQB: HLYK ), a leading digital healthcare company, today released its new application that provides a secure solution to one of healthcare’s most [...]
VPR Brands Provides Update on International Sales Progress
25/06/2019
· HoneyStick brand now available in EU with its newest distributor Near Dark in Germany · HoneyStick brand now available in Chile through AllGrano Distribución · HoneyStick brand now available direct to consumer on [...]
Auxly Announces Appointment of Andrew MacMillan as VP, Commercial Business Development
25/06/2019
VANCOUVER, British Columbia, June 25, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce the appointment of Andrew MacMillan as Vice President, [...]
Immutep Completes Patient Enrolment of the AIPAC Phase IIb Clinical Trial in Metastatic Breast Cancer
25/06/2019
226 patients with metastatic breast cancer have been enrolled in the AIPAC study Combination of eftilagimod alpha, an antigen presenting cell (APC) activator, administered in combination with chemotherapy is designed to [...]

Pages